FreeStyle Libre and Dexcom G4 Platinum sensors: Accuracy comparisons during two weeks of home use and use during experimentally induced glucose excursions

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 28, Issue 2, 2018, Pages 180-186

  Boscari, F ^a   Galasso, S ^a   Facchinetti, A ^a   Marescotti, M C ^a   Vallone, V ^a   Amato, A M L ^a   Avogaro, A ^a   Bruttomesso, D ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Accuracy; Continuous glucose monitoring (CGM); Flash glucose monitoring; Hypoglycaemia; Rate of change; Type 1 diabetes

Indexed keywords

CARBOHYDRATE; HEMOGLOBIN A1C; PARACETAMOL; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; INSULIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL RESEARCH; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFECTION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEAL; MIDDLE AGED; PERFORMANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; BLOOD GLUCOSE MONITORING; CHEMICALLY INDUCED; CONTROLLED STUDY; DEVICES; DRUG EFFECT; EQUIPMENT DESIGN; ITALY; METABOLISM; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; BIOMARKERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; EQUIPMENT DESIGN; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; ITALY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85039444504     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2017.10.023     Document Type: Article

References (18)

1. Diabetes Control and Complications Trial Study Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993), 977–986.
2. DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90 (1991), 450–459.
3. Davis, S., Alonso, M.D., Hypoglycemia as a barrier to glycemic control. J Diabetes Complicat 18:1 (2004), 60–68.
4. Deiss, D., Bolinder, J., Riveline, J.P., Battelino, T., Bosi, E., Tubiana-Rufi, N., et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 29:12 (2006), 2730–2732.
5. Hermanides, J., Nørgaard, K., Bruttomesso, D., Mathieu, C., Frid, A., Dayan, C.M., et al. Sensor augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabet Med 28 (2011), 1158–1167.
6. Hommel, E., Olsen, B., Battelino, T., Conget, I., Schütz-Fuhrmann, I., Hoogma, R., et al. Impact of continuous glucose monitoring on quality of life, treatment satisfaction and use of medical care resources: analyses from the SWITCH study. Acta Diabetol 51 (2014), 845–851.
7. Pickup, J.C., Freeman, S.C., Sutton, A.J., Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ, 343, 2011 d3805.
8. Heinemann, L., DeVries, J.H., Evidence for continuous glucose monitoring: sufficient for reimbursement?. Diabet Med 31 (2014), 122–125.
9. Lind, M., Polonsky, W., Hirsch, I.B., Heise, T., Bolinder, J., Dahlqvist, S., et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD Randomized Clinical Trial. JAMA 317 (2017), 379–387.
10. Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., et al., The SWITCH Study Group. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 55 (2012), 3155–3162.
11. Beck, R.W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND Randomized Clinical Trial. JAMA 317 (2017), 371–378.
12. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 359 (2008), 1464–1476.
13. Ólafsdóttir, A.F., Attvall, S., Sandgren, U., Dahlqvist, S., Pivodic, A., Skrtic, S., et al. A clinical trial of the accuracy and treatment experience of the Flash glucose monitor FreeStyle Libre in adults with type 1 diabetes. Diabetes Technol Ther 19:3 (2017), 164–172.
14. Aberer, F., Hajnsek, M., Rumpler, M., Zenz, S., Baumann, P.M., Elsayed, H., et al. Evaluation of subcutaneous glucose monitoring systems under routine environmental conditions in patients with type 1 diabetes. Diabetes Obes Metab, 2017 Feb 16, 10.1111/dom.12907 [Epub ahead of print] available from: https://www.ncbi.nlm.nih.gov/pubmed/28205324.
15. DeSalvo, D.J., Ly, T.T., Wadwa, R.P., Messer, L., Westfall, E., Gopisetty, D., et al. Continuous Glucose Sensor survival and accuracy over 14 consecutive days. Diabetes Care 39:8 (2016), e112–e113.
16. Wentholt, I.M., Hart, A.A., Hoekstra, J.B., Devries, J.H., How to assess and compare the accuracy of continuous glucose monitors?. Diabetes Technol Ther 10:2 (2008), 57–68.
17. Christiansen, M., Bailey, T., Watkins, E., Liljenquist, D., Price, D., Nakamura, K., et al. A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system. Diabetes Technol Ther 15:10 (2013), 881–888.
18. Cobelli, C., Schiavon, M., Dalla Man, C., Basu, A., Basu, R., Interstitial fluid glucose is not just a shifted-in-time but a distorted mirror of blood glucose: insight from an in silico study. Diabetes Technol Ther 18:8 (2016), 505–511.